Feraheme is an intravenous prescription medication used as a treatment of iron deficiency anemia in adult patients with chronic kidney disease. It has been approved to deliver a full gram of iron in two doses with demonstrated efficacy and safety. Feraheme is usually administered as a single IV push followed by a second dose via IV push 3 to 8 days later. In clinical trials common side effects included nausea, dizziness, hypotension, constipation, and peripheral edema. Your doctor should discuss other rare but potentially serious side effects and potential drug interactions with you prior to treatment.
Click here to view Manufacturers Website